Vanguard Personalized Indexing Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.09 Billion
- Q3 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 8,978 shares of ALNY stock, worth $2.38 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
8,978
Previous 7,153
25.51%
Holding current value
$2.38 Million
Previous $1.74 Million
42.06%
% of portfolio
0.04%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding ALNY
# of Institutions
654Shares Held
111MCall Options Held
2.14MPut Options Held
1.91M-
Capital World Investors Los Angeles, CA16.5MShares$4.37 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.34 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.53 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.39 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.31 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $32.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...